Showing results (21-30 of 90) with videos related to
Sort By:
Pageof 9
Applied Optics|June 22, 2010
Ray-tracing simulation method using piecewise quadratic interpolant for aspheric optical systemsShin-Ya Morita, Yohei Nishidate, Takashi Nagata, et al.Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|June 9, 2019
Enhancing effect of taurohyodeoxycholate on ABCB4-mediated phospholipid effluxYoshito Ikeda, Shin-Ya Morita, Ryo Hatano, et al.Chemistry and Physics of Lipids|June 26, 2012
Specific and sensitive enzymatic measurement of sphingomyelin in cultured cellsShin-ya Morita, Kuriko Soda, Reiko Teraoka, et al.Journal of Pharmaceutical Health Care and Sciences|April 24, 2025
Efficacy of 5-hydroxytryptamine 3 receptor antagonists versus metoclopramide for preventing nausea and vomiting during azacitidine chemotherapy in patients with myelodysplastic syndromes or acute leukemia: a retrospective observational studyYoshinori Wakasugi, Yoshito Ikeda, Satoshi Noda, et al.Biochimica Et Biophysica Acta|September 16, 2008
Cytotoxicity of lipid-free apolipoprotein BShin-ya Morita, Yuko Deharu, Eriko Takata, et al.Journal of Lipid Research|March 8, 2013
Bile salt-stimulated phospholipid efflux mediated by ABCB4 localized in nonraft membranesShin-ya Morita, Tadanori Tsuda, Manami Horikami, et al.Cancer Chemotherapy and Pharmacology|May 16, 2013
Pharmacokinetic interaction between sorafenib and prednisolone in a patient with hepatocellular carcinomaSatoshi Noda, Makoto Shioya, Daiki Hira, et al.Chemistry and Physics of Lipids|March 6, 2019
Effects of lipid composition on the structural properties of human serum amyloid A in reconstituted high-density lipoprotein particlesHiroka Takase, Masafumi Tanaka, Yuki Nakamura, et al.Chemical & Pharmaceutical Bulletin|December 3, 2009
Effect of pharmaceutical excipients on the stability of trichlormethiazide tablets under humid conditionsReiko Teraoka, Yuki Matsushima, Isao Sugimoto, et al.Biological & Pharmaceutical Bulletin|July 4, 2014
Reduction in gastrointestinal toxicity by gastric secretion inhibitors during S-1 monotherapy for patients with gastric cancerYugo Chisaki, Satoshi Noda, Daiki Hira, et al.Pageof 9